Joe Kaufmann, president and CEO of Kensey Nash, attributes the company’s economic success to an increase in the sports medicine business, which offset a slowdown in the spine business. The sales of Kensey Nash surgical products increased by 74 percent during the 2010 fiscal year compared to the previous year. During that time, Kensey Nash launched the XCM Biologic Tissue Materix.
Sports medicine products accounted for $16.4 million of sales during the 2010 fiscal year while spine products accounted for only $11.6 million. Kensey Nash reported net sales of $15.1 million, an increase of 12 percent from the previous fiscal year, and operating cash flow of $10.9 million.
The company reported $80.6 million in revenue and net sales of $54.3 million for the 2010 fiscal year. Both amounts are an increase from the previous year’s reported results.
Read the release on the fourth quarter and 2010 fiscal year report for Kensey Nash.
Read other coverage on Kensey Nash:
– Kensey Nash Receives CE Mark for Cartilage Repair Device
– Kensey Nash Reports Flat Biomaterials Sales, Decline in Orthopedic/Spine Sales
– Synthes Will Market Kensey Nash’s Reconstructive Surgical Products
